benefits of glp-1 receptor agonists Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity The Role of GLP-1RA Medications
Description
S.HadziahmetovicM
Front Endocrinol 12:645617
Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C
Finally, another 48-week phase 2 study in subjects with hepatic steatosis but not T2D results in a mean weight loss of 25.9% compared to 0.1% for placebo (107)
Latest study showing efficacy of nonpeptide oral GLP-1R agonists currently under development
